reference/19012021

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19012021

Outgoing Links

Predicate	Object
contentType	Journal Article
issn	2632-1297
issueIdentifier	1
pageRange	fcz050-
publicationName	Brain Communications
startingPage	fcz050
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d4194db12bc370677232dbbe46e17c73 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e4b7799b7b1f11aa93c9c8c1592f6892 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_06aba5a94448c92faf09747c7e7c67bd http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1537c0e93c03d926d046f3fde3bea46b
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_743b91435eb442cb9be841ffdfbdd96d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_440cc494924d43097075db65ef2a4823 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_44d92be8505edad54a6f945acdb69bc1
bibliographicCitation	Markey K, Mitchell J, Botfield H, Ottridge RS, Matthews T, Krishnan A, Woolley R, Westgate C, Yiangou A, Alimajstorovic Z, Shah P, Rick C, Ives N, Taylor AE, Gilligan LC, Jenkinson C, Arlt W, Scotton W, Fairclough RJ, Singhal R, Stewart PM, Tomlinson JW, Lavery GG, Mollan SP, Sinclair AJ. 11β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trial. Brain Commun. 2020;2(1):fcz050. PMID: 32954315; PMCID: PMC7425517.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_02a3dac56ae8c4ba5da13bd794139f2e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fd2a950868aecb11031209778c49ed4e http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1664-7541 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_159f799c7e07f35111ca68978491c4fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_962e37c9d90d2ccb1d86d6ca505be9b4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_020bccdfd1d0e1acaa8ca5d8fda05542 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_60882869643ee09131b9ca6f11aeccee http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a883d60b8e113fc0fd55ce593a15e0e7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_137bbcf9e2bc33741cbd900a3ccd5ab7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9396-7330 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dab89475b8c1dcc6f29401f474e6365e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_44b556d70b922c2e2a4f796d2deec6f7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1ba5bd1aa949ad97e137fc190ebc9cc8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_127607907256c01774edd314888011c7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fc3fd2eeba886f36352338dddf9e4064 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5f56ad42ad3db8c2bdf445dc5c6b38b4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1467da121658968bcfdb485a4edac542 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_45b897a1687bbb47c6eb224fc16562ca http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_21b85b79b9092e9c0ae0827348fe09cb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2b8f7366010ebacd34830f5d37750c48 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_65c623d9aedf91fd7827ae894b2bca8c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_434dae1ebc7972bdb98596f170527984 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_868bc49e004b63ccb6e34c2e04979120 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_011f32f1ec2982a4f587195b9fa09771 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9f587898387741dc1608de2bc9a5edc6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_13dd1ce708c130d8a41760b25ae33a51
date	2020-01-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1093/braincomms/fcaa108 https://pubmed.ncbi.nlm.nih.gov/PMC7425517 https://pubmed.ncbi.nlm.nih.gov/32954315 https://doi.org/10.1093/braincomms/fcz050
isPartOf	https://portal.issn.org/resource/ISSN/2632-1297 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/48953
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Corrigendum to: 11β-Hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled tria
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24946280 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5754 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9005 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8772 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222786 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5755 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7907

Total number of triples: 58.